News

Editor's Pick

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices
News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Author profile picture By L.A. McKeown
PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients
News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Author profile picture By Todd Neale
Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI
News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Author profile picture By Michael O'Riordan

Recent News

See all

Conference Coverage

See all
Sign Up for Our Newsletter

Stay up-to-date with breaking news, conference slides, and topical videos covering the spectrum of CVD.

Search All News

Filter by

Around the Web
See all
Pi-Cardia Reports First Commercial Cases with ShortCut™
First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction.
Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States